Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP429124.RAfIB5meFvSlroAc7emkRDLO2M7XWOyMi_5gvKLrIFlqo130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429124.RAfIB5meFvSlroAc7emkRDLO2M7XWOyMi_5gvKLrIFlqo130_provenance.
• NP303395.RAllf18-WHIQ93wVicQXS2WiFHg9B3w1yMttsAla9MMwo130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303395.RAllf18-WHIQ93wVicQXS2WiFHg9B3w1yMttsAla9MMwo130_provenance.
• NP784571.RAAbs0s8D-Ox0WsJvPKO0Z6CbK0-d14HlbhmiaqdJtYg8130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784571.RAAbs0s8D-Ox0WsJvPKO0Z6CbK0-d14HlbhmiaqdJtYg8130_provenance.
• NP201466.RAm9fVZanaqIWpqsjmIWGJ9gx6eQp8P9uP5484WGf1cmE130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201466.RAm9fVZanaqIWpqsjmIWGJ9gx6eQp8P9uP5484WGf1cmE130_provenance.
• NP545910.RAiQVofK_h0wkIvkexUH1Z_FFaMvxQhQxHEXTTNZECeu8130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545910.RAiQVofK_h0wkIvkexUH1Z_FFaMvxQhQxHEXTTNZECeu8130_provenance.
• NP711950.RABVnRRFCBdVaGPPvWEzmYVbJLPoXJQ_5S6BE7k6FjnyA130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711950.RABVnRRFCBdVaGPPvWEzmYVbJLPoXJQ_5S6BE7k6FjnyA130_provenance.
• NP739632.RAsGNJaAjJf7l6LkkzzKteCv2q9dSEK8Mcc0BDUrlP7pM130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739632.RAsGNJaAjJf7l6LkkzzKteCv2q9dSEK8Mcc0BDUrlP7pM130_provenance.
• NP735989.RAhbcBO8rawINiYrBq05BcsYCxubfMZ0oZYnE4d8KkRUo130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735989.RAhbcBO8rawINiYrBq05BcsYCxubfMZ0oZYnE4d8KkRUo130_provenance.
• NP469886.RAZ2vZY169EA1B0iv9ZCLiabuOPW81Tl-rHHb7IwNs_9M130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469886.RAZ2vZY169EA1B0iv9ZCLiabuOPW81Tl-rHHb7IwNs_9M130_provenance.
• NP720394.RAegXIbbPShqy-gjO8a-w7BKDu6OaTDfMc4R1YJBXYTq4130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720394.RAegXIbbPShqy-gjO8a-w7BKDu6OaTDfMc4R1YJBXYTq4130_provenance.
• NP312405.RAxIJiIUVdzcFinUzLe1cy02DcbnmJxRzg3W3W7rksunY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312405.RAxIJiIUVdzcFinUzLe1cy02DcbnmJxRzg3W3W7rksunY130_provenance.
• NP558985.RAysXrX0lAdsy-aeN4Un_HkWXc260NLVA6JNa3iT15sxc130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558985.RAysXrX0lAdsy-aeN4Un_HkWXc260NLVA6JNa3iT15sxc130_provenance.
• NP338551.RAfo6zzijvXxD7MP4ldVEDbKpPS7LvpdOSMEtndvFSGlY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338551.RAfo6zzijvXxD7MP4ldVEDbKpPS7LvpdOSMEtndvFSGlY130_provenance.
• NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.
• NP724965.RA1MkvamvYPC79EkI1ehB587bWlNFDZ_pgcSDLUAm-pok130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724965.RA1MkvamvYPC79EkI1ehB587bWlNFDZ_pgcSDLUAm-pok130_provenance.
• NP819127.RAytodmnfwFCRGlUMlVSkGqZO6XTssB76Tvy8RWkd9MM0130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819127.RAytodmnfwFCRGlUMlVSkGqZO6XTssB76Tvy8RWkd9MM0130_provenance.
• NP876271.RA9jiOfgyuf5y7yFjaPHAbkxXtHf6kdJ0bNTNrGXPQaM0130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876271.RA9jiOfgyuf5y7yFjaPHAbkxXtHf6kdJ0bNTNrGXPQaM0130_provenance.
• NP833756.RAaHNsXtJzS_yXChkH4zwKWxSXxZQfdOO3Nv8nb0H1GIU130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833756.RAaHNsXtJzS_yXChkH4zwKWxSXxZQfdOO3Nv8nb0H1GIU130_provenance.
• NP838396.RARt4V8hYeGieewJRlsivPHDNSPy5AuYBzMa8fw1BM9TA130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838396.RARt4V8hYeGieewJRlsivPHDNSPy5AuYBzMa8fw1BM9TA130_provenance.
• NP710129.RAX_frH-Lygzjx_coF9c6iRae314SkHdNSvspi3UVfUn4130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710129.RAX_frH-Lygzjx_coF9c6iRae314SkHdNSvspi3UVfUn4130_provenance.
• NP1005065.RAZ0KdbKGatcO2xnpVfQ_ZM926jnFKSXo3rl1CfT0c0GY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005065.RAZ0KdbKGatcO2xnpVfQ_ZM926jnFKSXo3rl1CfT0c0GY130_provenance.
• NP929687.RAerNrHcedT-HZC0JBYch7DuqJiCMdRHEdHI5qLtJTHsg130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929687.RAerNrHcedT-HZC0JBYch7DuqJiCMdRHEdHI5qLtJTHsg130_provenance.
• NP929692.RAdFkXOaH_rhc-Ao-9OqDCCChsqEqGFkDKo2EYr8zp3e8130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929692.RAdFkXOaH_rhc-Ao-9OqDCCChsqEqGFkDKo2EYr8zp3e8130_provenance.
• NP929694.RAWojHZEpc99F-OZvu5YO6kjJk5BVEKFvcLOuheRSkMCY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929694.RAWojHZEpc99F-OZvu5YO6kjJk5BVEKFvcLOuheRSkMCY130_provenance.
• NP283064.RAmdUQ2xaUSFp2YYB30pf--GdrMU1vWZPpcQUnsy_UjyI130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283064.RAmdUQ2xaUSFp2YYB30pf--GdrMU1vWZPpcQUnsy_UjyI130_provenance.
• NP929689.RAA3IxQUhIYmWm3pcTlam_ht8X0tDb3PYVRTsaRuSpPk4130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929689.RAA3IxQUhIYmWm3pcTlam_ht8X0tDb3PYVRTsaRuSpPk4130_provenance.
• NP929696.RACSyQlVjPdZDETy_AoSAjcyTtZbXLaUsmYpWB7jHGRbY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929696.RACSyQlVjPdZDETy_AoSAjcyTtZbXLaUsmYpWB7jHGRbY130_provenance.
• NP642247.RAvcxsNhFBFBoI6VVN_uO2t9FKNoURiLdJIAPNktt0ces130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642247.RAvcxsNhFBFBoI6VVN_uO2t9FKNoURiLdJIAPNktt0ces130_provenance.
• NP1005035.RAt3XEMNBaKVWr2LRguTnHx7Dz16eUnJtPcFisu8pgdjg130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005035.RAt3XEMNBaKVWr2LRguTnHx7Dz16eUnJtPcFisu8pgdjg130_provenance.
• NP830547.RAKtDIKr13Xr0C38qa6C6ceLKQtX8XNdov_Onx09g0DL0130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830547.RAKtDIKr13Xr0C38qa6C6ceLKQtX8XNdov_Onx09g0DL0130_provenance.
• NP929686.RAv2rE5jbzGTGzaSd3UwF57lAiZiYDtDe-vemyd8E8vcQ130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929686.RAv2rE5jbzGTGzaSd3UwF57lAiZiYDtDe-vemyd8E8vcQ130_provenance.
• NP929690.RAmY6RdyiuZgNPB19Pi8bkIweQ6-Di-0aA-TBFY-B87GI130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929690.RAmY6RdyiuZgNPB19Pi8bkIweQ6-Di-0aA-TBFY-B87GI130_provenance.
• NP929695.RAv3JHPPopgJGM5XZvqaDeh0-ktR_w3evOkQWSTDpCbSU130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929695.RAv3JHPPopgJGM5XZvqaDeh0-ktR_w3evOkQWSTDpCbSU130_provenance.
• NP929697.RAuz1pZpODYV_f4cs3K84Je3t-Cy72op6kZ_v4L388X8E130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929697.RAuz1pZpODYV_f4cs3K84Je3t-Cy72op6kZ_v4L388X8E130_provenance.
• NP929699.RAnkHNtdZKGgbv7ebqMc_t2RV4k3BtKCuDjvZvxeQbX0Y130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929699.RAnkHNtdZKGgbv7ebqMc_t2RV4k3BtKCuDjvZvxeQbX0Y130_provenance.
• NP338604.RA5CwZbmGvSolHPqgNMoCMNG74EKrSHxl7iCpeqZBTZ4w130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338604.RA5CwZbmGvSolHPqgNMoCMNG74EKrSHxl7iCpeqZBTZ4w130_provenance.
• NP252606.RAyM-ktygLGFp7wsZak2mX9NSJ5_mqZarH-ii-ckKjO7U130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252606.RAyM-ktygLGFp7wsZak2mX9NSJ5_mqZarH-ii-ckKjO7U130_provenance.
• NP642370.RAO_pXbbSQ6PfV3AhEV7cQ_1H8kssaK7J-9pARCf1lt0o130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642370.RAO_pXbbSQ6PfV3AhEV7cQ_1H8kssaK7J-9pARCf1lt0o130_provenance.
• NP252572.RAKqE_Mwuvwe0207R57rCP0ptIc6kuLZaBkO0bh7grjPg130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252572.RAKqE_Mwuvwe0207R57rCP0ptIc6kuLZaBkO0bh7grjPg130_provenance.
• NP710189.RAFVETfTuuX7_d4q4HR07gLSaSbvB8CUepxYTa0RWnqyY130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710189.RAFVETfTuuX7_d4q4HR07gLSaSbvB8CUepxYTa0RWnqyY130_provenance.
• NP833717.RAFzfL4k-L8TMlFYvRsarMw0Gtn7IWgqOPdiZONIntnrc130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833717.RAFzfL4k-L8TMlFYvRsarMw0Gtn7IWgqOPdiZONIntnrc130_provenance.
• NP929685.RAN4qhVyvC8bvFrx9QIPAKsVKrIBuV6f6VE_JVTMDHC6g130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929685.RAN4qhVyvC8bvFrx9QIPAKsVKrIBuV6f6VE_JVTMDHC6g130_provenance.
• NP929691.RAEfhREn97y_W8KJUEzwelFz6k7JlMF04_bDuzHWXPpiE130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929691.RAEfhREn97y_W8KJUEzwelFz6k7JlMF04_bDuzHWXPpiE130_provenance.
• NP929693.RAInbNP1m9a6KcBra9o1wc3hgOXHcZjYvvyaPdTPaMmxQ130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929693.RAInbNP1m9a6KcBra9o1wc3hgOXHcZjYvvyaPdTPaMmxQ130_provenance.
• NP929700.RAJT6PqAf6VPyrJ19-2ZQoFBhWrmN7TyF1LK_xMsx9ePU130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929700.RAJT6PqAf6VPyrJ19-2ZQoFBhWrmN7TyF1LK_xMsx9ePU130_provenance.
• NP838427.RA65A0p7Cykh0mV8GIZ0z1_btGZ1SHDyQH9DpcOFSQCMU130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838427.RA65A0p7Cykh0mV8GIZ0z1_btGZ1SHDyQH9DpcOFSQCMU130_provenance.
• NP929684.RA8HHSARAshhcWYMYwzzbWrMobGRtvUsok2IFcNq4Izmw130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929684.RA8HHSARAshhcWYMYwzzbWrMobGRtvUsok2IFcNq4Izmw130_provenance.
• NP929688.RA-NG-oXMzcqfd4V5oebEh7CE-__bETrqjUjETCQQsA-I130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929688.RA-NG-oXMzcqfd4V5oebEh7CE-__bETrqjUjETCQQsA-I130_provenance.